Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03368066

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03368066
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03368066. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-01-29 (actual); primary completion 2019-03-12 (actual). Results posted on 2021-12-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
Condition
Adrenal Insufficiency
Condition
Cirrhosis
Condition
Spur Cell Anemia
Condition
Lecithin Acyltransferase Deficiency
Intervention (Drug)
Cosyntropin
Lead sponsor
University of Virginia (class: other)

Record details

Record id
cardio:ct-nct03368066
Content hash
c4fda0744b3642a327a335f96e5376cda940e7269e0b20d7a220d8586c74c4b6